Human neutrophil NADPH-oxidase activity is inhibited by lazaroids

Inflammation

Volumn 20, Issue 2, 1996, Pages 139-150

  Theron, A J ^a   Anderson, R ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]METHYL] 3,4 DIHYDRO 2,5,7,8 TETRAMETHYL 2H 1 BENZOPYRAN 6 OL; 21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; 21 [4 [5,6 BIS(DIETHYLAMINO) 2 PYRIDYL] 1 PIPERAZINYL] 16ALPHA METHYLPREGNA 1,4,9(11) TRIENE 3,20 DIONE; ARACHIDONIC ACID; LAZAROID; LYSOPHOSPHATIDYLCHOLINE; MEMBRANE ENZYME; PHOSPHOLIPASE A2; PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER;

ADULT; ARTICLE; CALCIUM TRANSPORT; CELL ENERGY; CELL MEMBRANE; CELL METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NEUTROPHIL; NORMAL HUMAN; OXYGEN CONSUMPTION;

ADENOSINE TRIPHOSPHATE; CALCIUM; CHROMANS; FREE RADICAL SCAVENGERS; HUMANS; NADPH OXIDASE; NEUTROPHILS; OXIDATION-REDUCTION; PHOSPHOLIPASES A; PIPERAZINES; PREGNATRIENES; PROTEIN KINASE C; RESPIRATORY BURST; SUPEROXIDES;

EID: 0029874056     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01487401     Document Type: Article

References (34)

1. BABIOR, B. M. 1984. Oxidants from phagocytes: agents of defense and destruction. Blood 64:959-964.
2. ANDERSON, R. 1991. Phagocyte-derived reactive oxidants as mediators of inflammation-associated tissue damage. S. Afr. J. Sci. 87:594-596.
3. EL-HAG, A., P. E. LIPSKY, M. BENNETT, and R. A. CLARK. 1986. Immunomodulation by neutrophil myeloperoxidase and hydrogen peroxide: differential susceptibility of human lymphocyte functions. J. Immunol. 136:3420-3426.
4. WEITZMAN, S. A., A. B. WEITBERG, E. P. CLARK, and T. P. STOSSEL. 1985. Phagocytes as carcinogens: malignant transformation produced by human neutrophils. Science 227:1231-1233.
5. WEISS, S. J. 1989. Tissue destruction by neutrophils. N. Eng. Med. J. 320:365-376.
6. WITZTUM, J. L., and D. STEINBERG. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1785-1792.
7. PATEL, K. D., G. A. ZIMMERMAN, S. M. PRESCOTT, R. P. MCEVER, and T. M. MCINTYRE. 1991. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J. Cell Biol. 112:749-759.
8. GRIMM, R. H. JR., J. D. NEATON, and W. LUDWIG. 1985. Prognostic importance of the white cell count for coronary, cancer and all-cause mortality. JAMA 254:1932-1937.
9. DE LABRY, L. O., E. W. CAMPION, R. J. GLYNN, and P. L. VOKONAS. 1990. White blood cell count as a predictor of mortality: results over 18 years from the normative aging study. J. Clin. Epidemiol. 43:153-157.
10. FRIEDMAN, G. D., J. V. SELBY, and C. P. QUESENBERRY, JR. 1990. The leukocyte count: a predictor of hypertension. J. Clin. Epidemiol. 43:907-911.
11. FRIEDMAN, G. D., and B. H. FIREMAN. 1991. The leukocyte count and cancer mortality. Am. J. Epidemiol. 133:376-380.
12. PHILLIPS, A. N., J. D. NEATON, D. G. COOK, R. H. GRIMM, and A. G. SHAPER. 1992. Leukocyte count and risk of major coronary heart disease events. Am. J. Epidemiol. 136:59-70.
13. PHILLIPS, A. N., J. D. NEATON, D. G. COOK, R. H. GRIMM, and A. G. SHAPER. 1992. The leukocyte count and risk of lung cancer. Cancer 69:68-684.
14. BRAUGHLER, J. M., J. F. PREGENZER, R. L. CHASE, L. A. DUNCAN, E. J. JACOBSEN, and J. M. MCCALL. 1987. Novel 21-aminosteroids as potent inhibitors of iron-dependent lipid peroxidation. J. Biol. Chem. 262:10438-10440.
15. JACOBSON, A. J., J. M. MCCALL, D. E. AYER, F. J. VAN DOORNIK, J. R. PALMER, K. L. BELONGA, J. M. BRAUGHLER, E. D. HALL, D. J. HOUGER, M. A. KROOK, and T. A. RUNGE. 1990. Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma. J. Med. Chem. 33:1145-1151.
16. HALL, E. D., and P. A. YONKERS. 1988. Attenuation of post-ischemic cerebral hypoperfusion by the 21-aminosteroid U74006F. Stroke 19:340-344.
17. NATALE, J. E., R. J. SCHOTT, E. D. HALL, J. M. BRAUGHLER, and L. G. D'ALECY. 1988. Effect of the aminosteroid U74006F after cardiopulmonary arrest in dogs. Stroke 19:1371-1378.
18. HALL, E. D., P. A. YONKERS, K. L. HORAN, and J. M. BRAUGHLER. 1989. Correlation between attenuation of post-traumatic spinal chord ischemia and preservation of tissue vitamin E by the 21-aminosteroid U74006F: Evidence for an in vivo antioxidant mechanism. J. Neurotrauma. 6:169-176.
19. STEINKE, D. E., B. K. A. WEIR, J. M. FINDLAY, T. TANABE, M. GRACE, and B. W. KRUSHELNYCKY. 1989. A trial of the 21-aminosteroids U74006F in a primate model of chronic cerebral vasospasm. Neurosurgery 24:179-186.
20. HOLZGREFE, H. H., L. V. BUCHANAN, and J. K. GIBSON. 1990. Effect of U74006F in stunned reperfused canine myocardium. J. Cardiovasc. Pharmacol. 15:239-248.
21. 4 mobilizes calcium without the breakdown of polyphosphoinositides and the production of phosphatidic acid in rabbit neutrophils. Proc. Natl. Acad. Sci. U.S.A. 81:5966-5969.
22. MINKENBERG, I., and E. FERBER. 1984. Lucigenin-dependent chemiluminescence as a new assay for NADPH-oxidase activity in particulate fractions of human polymorphonuclear leukocytes. J. Immunol. Meth. 71:61-67.
23. THERON, A. J., K. J. STEENKAMP, and R. ANDERSON. 1994. The NADPH-oxidase activity of stimulated neutrophils is markedly increased by serum. Inflammation 18:459-467.
24. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450.
25. HOLMSEN, H. E., E. STORM, and H. J. DAY. 1972. Determinations of ATP and ADP in blood platelets: a modification of the firefly luciferase assay for plasma. Anal. Biochem. 46:481-501.
26. BRAUGHLER, J. M., E. D. HALL, E. J. JACOBSEN, J. M. MCCALL, and E. E. MEANS. 1989. The 21-aminosteroids: Potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia. Drugs Future 14:143-152.
27. FISHER, M., P. LEVINE, and R. A. COHEN. 1990. A 21-aminosteroid reduces hydrogen peroxide generation by and chemiluminescence of stimulated human leukocytes. Stroke 21:1435-1438.
28. THOMAS, P. D., G. D. MAO, A. RABINOVITCH, and M. J. POZNANSKY. 1993. Inhibition of superoxide-generating NADPH oxidase of human neutrophils by lazaroids (21-aminosteroids and 2-methylaminochromans). Biochem. Pharmacol. 45:241-251.
29. HEYWORTH, P. G., and J. A. BADWEY. 1993. Continuous phosphorylation of both the 47 and 49 kDa proteins occurs during superoxide production by neutrophils. Biochem. Biophys. Acta. 1051:299-305.
30. ANDERSON, R., C. E. J. VAN RENSBURG, G. K. JOONE, and A. LESSING. 1991. Auranofin inactivates phosphofructokinase in human neutrophils, leading to depletion of intracellular ATP and inhibition of superoxide generation and locomotion. Mol. Pharmacol. 40:427-434.
31. 2 for activation of the assembled NADPH oxidase in human neutrophils. Biochem. J. 297:217-233.
32. RUBINEK, T., and R. LEVY. 1993. Arachidonic acid increases the activity of the assembled NADPH oxidase in cytoplasmic membranes and endosomes. Biochem. Biophys. Acta. 1176:51-58.
33. CAO, Y. Z., O. KARMIN, P. C. CHOY, and A. C. CHAN. 1989. Regulation by vitamin E of phosphatidylcholine metabolism in rat heart. Biochem. J. 147:135-140.
34. TRAN, K., and A. C. CHAN. 1988. Effect of VE enrichment on arachidonate acid release and cellular phospholipids in cultured human endothelial cells. Biochem. Biophys. Acta. 963:468-478.